SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2obh'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1A29_A_TFPA153_1
(CALMODULIN)		 2obh CENTRIN-2
(Homo
sapiens) 		5 / 8 ILE A 121
LEU A 126
MET A 145
ALA A 149
VAL A 157
 None
None
None
None
CA  A1001 ( 4.9A)
 0.38A 1a29A-2obhA:
12.4		 1a29A-2obhA:
52.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1A29_A_TFPA153_1
(CALMODULIN)		 2obh CENTRIN-2
(Homo
sapiens) 		5 / 8 ILE A 121
LEU A 126
MET A 145
GLU A 148
ALA A 149
 None
 0.98A 1a29A-2obhA:
12.4		 1a29A-2obhA:
52.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1CTR_A_TFPA153_1
(CALMODULIN)		 2obh CENTRIN-2
(Homo
sapiens) 		5 / 9 ILE A 121
LEU A 126
MET A 145
ALA A 149
VAL A 157
 None
None
None
None
CA  A1001 ( 4.9A)
 0.61A 1ctrA-2obhA:
12.7		 1ctrA-2obhA:
52.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1CTR_A_TFPA153_1
(CALMODULIN)		 2obh CENTRIN-2
(Homo
sapiens) 		5 / 9 LEU A 126
MET A 145
GLU A 148
ALA A 149
VAL A 157
 None
None
None
None
CA  A1001 ( 4.9A)
 0.99A 1ctrA-2obhA:
12.7		 1ctrA-2obhA:
52.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1DTL_A_BEPA204_1
(CARDIAC TROPONIN C)		 2obh CENTRIN-2
(Homo
sapiens) 		5 / 11 PHE A 113
ILE A 121
LEU A 126
LEU A 133
MET A 145
 None
 0.52A 1dtlA-2obhA:
11.5		 1dtlA-2obhA:
40.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1K2R_A_H4BA1760_1
(NITRIC-OXIDE
SYNTHASE)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.45A 1k2rA-2obhA:
undetectable
1k2rB-2obhA:
undetectable		 1k2rA-2obhA:
17.13
1k2rB-2obhA:
17.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1LIN_A_TFPA156_1
(CALMODULIN)		 2obh CENTRIN-2
(Homo
sapiens) 		5 / 8 ILE A 121
LEU A 126
MET A 145
ILE A 146
GLU A 148
 None
 0.96A 1linA-2obhA:
12.9		 1linA-2obhA:
52.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1LXF_C_BEPC92_1
(TROPONIN C, SLOW
SKELETAL AND CARDIAC
MUSCLES)		 2obh CENTRIN-2
(Homo
sapiens) 		6 / 12 ILE A 121
LEU A 133
MET A 145
ILE A 146
GLU A 148
VAL A 157
 None
None
None
None
None
CA  A1001 ( 4.9A)
 1.05A 1lxfC-2obhA:
7.8		 1lxfC-2obhA:
31.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LZX_B_H4BB1760_1
(NITRIC-OXIDE
SYNTHASE)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.40A 1lzxA-2obhA:
undetectable
1lzxB-2obhA:
undetectable		 1lzxA-2obhA:
17.13
1lzxB-2obhA:
17.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MMV_B_H4BB2760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.39A 1mmvA-2obhA:
undetectable
1mmvB-2obhA:
undetectable		 1mmvA-2obhA:
17.13
1mmvB-2obhA:
17.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1P6H_B_H4BB761_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.36A 1p6hA-2obhA:
undetectable
1p6hB-2obhA:
undetectable		 1p6hA-2obhA:
17.13
1p6hB-2obhA:
17.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1P6K_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.29A 1p6kA-2obhA:
1.0
1p6kB-2obhA:
undetectable		 1p6kA-2obhA:
17.13
1p6kB-2obhA:
17.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1P6K_B_H4BB761_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.29A 1p6kA-2obhA:
undetectable
1p6kB-2obhA:
undetectable		 1p6kA-2obhA:
17.13
1p6kB-2obhA:
17.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RS6_B_H4BB761_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 8 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.35A 1rs6A-2obhA:
undetectable
1rs6B-2obhA:
undetectable		 1rs6A-2obhA:
17.13
1rs6B-2obhA:
17.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3B3P_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.49A 3b3pA-2obhA:
undetectable
3b3pB-2obhA:
undetectable		 3b3pA-2obhA:
17.09
3b3pB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DZY_A_9CRA463_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 2obh CENTRIN-2
(Homo
sapiens) 		5 / 12 ILE A  33
ALA A  36
ASN A  85
LEU A  60
ALA A  56
 None
 1.08A 3dzyA-2obhA:
undetectable		 3dzyA-2obhA:
13.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HSO_B_H4BB1760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.44A 3hsoA-2obhA:
undetectable
3hsoB-2obhA:
undetectable		 3hsoA-2obhA:
17.09
3hsoB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JT5_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.49A 3jt5A-2obhA:
undetectable
3jt5B-2obhA:
undetectable		 3jt5A-2obhA:
17.09
3jt5B-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N5V_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.48A 3n5vA-2obhA:
undetectable
3n5vB-2obhA:
undetectable		 3n5vA-2obhA:
17.09
3n5vB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N5Z_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.47A 3n5zA-2obhA:
undetectable
3n5zB-2obhA:
undetectable		 3n5zA-2obhA:
17.09
3n5zB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N65_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 6 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.39A 3n65A-2obhA:
1.6
3n65B-2obhA:
0.0		 3n65A-2obhA:
17.09
3n65B-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SVP_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.47A 3svpA-2obhA:
undetectable
3svpB-2obhA:
undetectable		 3svpA-2obhA:
17.09
3svpB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFO_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.44A 3ufoA-2obhA:
undetectable
3ufoB-2obhA:
undetectable		 3ufoA-2obhA:
17.09
3ufoB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFP_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.39A 3ufpA-2obhA:
undetectable
3ufpB-2obhA:
undetectable		 3ufpA-2obhA:
17.09
3ufpB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFP_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.40A 3ufpA-2obhA:
undetectable
3ufpB-2obhA:
undetectable		 3ufpA-2obhA:
17.09
3ufpB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFQ_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.41A 3ufqA-2obhA:
undetectable
3ufqB-2obhA:
undetectable		 3ufqA-2obhA:
17.09
3ufqB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFR_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.35A 3ufrA-2obhA:
undetectable
3ufrB-2obhA:
undetectable		 3ufrA-2obhA:
17.09
3ufrB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFS_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.38A 3ufsA-2obhA:
undetectable
3ufsB-2obhA:
undetectable		 3ufsA-2obhA:
17.09
3ufsB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFT_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.49A 3uftA-2obhA:
undetectable
3uftB-2obhA:
undetectable		 3uftA-2obhA:
17.09
3uftB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFV_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.44A 3ufvA-2obhA:
undetectable
3ufvB-2obhA:
undetectable		 3ufvA-2obhA:
17.09
3ufvB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFV_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.38A 3ufvA-2obhA:
undetectable
3ufvB-2obhA:
undetectable		 3ufvA-2obhA:
17.09
3ufvB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C39_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.28A 4c39A-2obhA:
undetectable
4c39B-2obhA:
undetectable		 4c39A-2obhA:
17.09
4c39B-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C39_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.29A 4c39A-2obhA:
undetectable
4c39B-2obhA:
undetectable		 4c39A-2obhA:
17.09
4c39B-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTP_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.32A 4ctpA-2obhA:
undetectable
4ctpB-2obhA:
undetectable		 4ctpA-2obhA:
17.09
4ctpB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTQ_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.29A 4ctqA-2obhA:
undetectable
4ctqB-2obhA:
undetectable		 4ctqA-2obhA:
17.09
4ctqB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTR_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.46A 4ctrA-2obhA:
undetectable
4ctrB-2obhA:
undetectable		 4ctrA-2obhA:
17.09
4ctrB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTT_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.42A 4cttA-2obhA:
undetectable
4cttB-2obhA:
undetectable		 4cttA-2obhA:
17.09
4cttB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CX6_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.29A 4cx6A-2obhA:
undetectable
4cx6B-2obhA:
undetectable		 4cx6A-2obhA:
17.09
4cx6B-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D1N_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.48A 4d1nA-2obhA:
undetectable
4d1nB-2obhA:
undetectable		 4d1nA-2obhA:
16.14
4d1nB-2obhA:
16.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D31_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.41A 4d31A-2obhA:
undetectable
4d31B-2obhA:
undetectable		 4d31A-2obhA:
17.09
4d31B-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EUX_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.45A 4euxA-2obhA:
undetectable
4euxB-2obhA:
undetectable		 4euxA-2obhA:
17.09
4euxB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4IMW_A_H4BA805_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.48A 4imwA-2obhA:
undetectable
4imwB-2obhA:
undetectable		 4imwA-2obhA:
17.09
4imwB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JSF_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.34A 4jsfA-2obhA:
undetectable
4jsfB-2obhA:
undetectable		 4jsfA-2obhA:
17.09
4jsfB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JSG_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.48A 4jsgA-2obhA:
undetectable
4jsgB-2obhA:
undetectable		 4jsgA-2obhA:
17.09
4jsgB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JSG_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.33A 4jsgA-2obhA:
undetectable
4jsgB-2obhA:
undetectable		 4jsgA-2obhA:
17.09
4jsgB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K5D_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.37A 4k5dA-2obhA:
undetectable
4k5dB-2obhA:
undetectable		 4k5dA-2obhA:
17.09
4k5dB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K5E_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.45A 4k5eA-2obhA:
undetectable
4k5eB-2obhA:
undetectable		 4k5eA-2obhA:
17.09
4k5eB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K5F_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.47A 4k5fA-2obhA:
undetectable
4k5fB-2obhA:
undetectable		 4k5fA-2obhA:
17.09
4k5fB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K5G_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.31A 4k5gA-2obhA:
undetectable
4k5gB-2obhA:
undetectable		 4k5gA-2obhA:
17.09
4k5gB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KCJ_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.38A 4kcjA-2obhA:
undetectable
4kcjB-2obhA:
undetectable		 4kcjA-2obhA:
17.09
4kcjB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LUX_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.34A 4luxA-2obhA:
undetectable
4luxB-2obhA:
undetectable		 4luxA-2obhA:
17.09
4luxB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LUX_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.30A 4luxA-2obhA:
undetectable
4luxB-2obhA:
undetectable		 4luxA-2obhA:
17.09
4luxB-2obhA:
17.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RJD_A_TFPA203_1
(CALMODULIN)		 2obh CENTRIN-2
(Homo
sapiens) 		5 / 8 ILE A 121
LEU A 126
MET A 145
ALA A 149
VAL A 157
 None
None
None
None
CA  A1001 ( 4.9A)
 0.47A 4rjdA-2obhA:
13.3		 4rjdA-2obhA:
30.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RJD_A_TFPA203_1
(CALMODULIN)		 2obh CENTRIN-2
(Homo
sapiens) 		5 / 8 PHE A 113
ILE A 121
LEU A 126
MET A 145
VAL A 157
 None
None
None
None
CA  A1001 ( 4.9A)
 0.64A 4rjdA-2obhA:
13.3		 4rjdA-2obhA:
30.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RJD_B_TFPB203_1
(CALMODULIN)		 2obh CENTRIN-2
(Homo
sapiens) 		5 / 7 PHE A 113
LEU A 126
MET A 145
ALA A 149
MET A 166
 None
 0.70A 4rjdB-2obhA:
13.1		 4rjdB-2obhA:
30.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UCH_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.30A 4uchA-2obhA:
undetectable
4uchB-2obhA:
undetectable		 4uchA-2obhA:
16.30
4uchB-2obhA:
16.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UCH_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 8 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.38A 4uchA-2obhA:
undetectable
4uchB-2obhA:
undetectable		 4uchA-2obhA:
16.30
4uchB-2obhA:
16.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UGZ_B_H4BB760_1
(NEURONAL NITRIC
OXIDE SYNTHASE)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.33A 4ugzA-2obhA:
undetectable
4ugzB-2obhA:
undetectable		 4ugzA-2obhA:
17.09
4ugzB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH0_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.34A 4uh0A-2obhA:
undetectable
4uh0B-2obhA:
undetectable		 4uh0A-2obhA:
17.09
4uh0B-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH1_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.49A 4uh1A-2obhA:
undetectable
4uh1B-2obhA:
undetectable		 4uh1A-2obhA:
17.09
4uh1B-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH2_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.35A 4uh2A-2obhA:
undetectable
4uh2B-2obhA:
undetectable		 4uh2A-2obhA:
17.09
4uh2B-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH3_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.31A 4uh3A-2obhA:
undetectable
4uh3B-2obhA:
undetectable		 4uh3A-2obhA:
17.09
4uh3B-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH4_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.36A 4uh4A-2obhA:
undetectable
4uh4B-2obhA:
undetectable		 4uh4A-2obhA:
17.09
4uh4B-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH5_A_H4BA760_1
(NEURONAL NITRIC
OXIDE SYNTHASE)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.39A 4uh5A-2obhA:
undetectable
4uh5B-2obhA:
undetectable		 4uh5A-2obhA:
16.34
4uh5B-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH5_B_H4BB760_1
(NEURONAL NITRIC
OXIDE SYNTHASE)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.28A 4uh5A-2obhA:
undetectable
4uh5B-2obhA:
undetectable		 4uh5A-2obhA:
16.34
4uh5B-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH6_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.31A 4uh6A-2obhA:
undetectable
4uh6B-2obhA:
undetectable		 4uh6A-2obhA:
16.34
4uh6B-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH6_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.26A 4uh6A-2obhA:
undetectable
4uh6B-2obhA:
undetectable		 4uh6A-2obhA:
16.34
4uh6B-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V3W_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 6 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.40A 4v3wA-2obhA:
undetectable
4v3wB-2obhA:
undetectable		 4v3wA-2obhA:
17.09
4v3wB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AD4_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.35A 5ad4A-2obhA:
undetectable
5ad4B-2obhA:
undetectable		 5ad4A-2obhA:
17.09
5ad4B-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AD4_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.34A 5ad4A-2obhA:
undetectable
5ad4B-2obhA:
undetectable		 5ad4A-2obhA:
17.09
5ad4B-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AD5_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.33A 5ad5A-2obhA:
undetectable
5ad5B-2obhA:
undetectable		 5ad5A-2obhA:
17.09
5ad5B-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AD6_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.39A 5ad6A-2obhA:
undetectable
5ad6B-2obhA:
undetectable		 5ad6A-2obhA:
17.09
5ad6B-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AD6_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.29A 5ad6A-2obhA:
undetectable
5ad6B-2obhA:
undetectable		 5ad6A-2obhA:
17.09
5ad6B-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADA_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.33A 5adaA-2obhA:
undetectable
5adaB-2obhA:
undetectable		 5adaA-2obhA:
17.09
5adaB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADA_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.32A 5adaA-2obhA:
undetectable
5adaB-2obhA:
undetectable		 5adaA-2obhA:
17.09
5adaB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADF_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.40A 5adfA-2obhA:
undetectable
5adfB-2obhA:
undetectable		 5adfA-2obhA:
16.34
5adfB-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADG_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.31A 5adgA-2obhA:
undetectable
5adgB-2obhA:
undetectable		 5adgA-2obhA:
16.34
5adgB-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADG_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.27A 5adgA-2obhA:
undetectable
5adgB-2obhA:
undetectable		 5adgA-2obhA:
16.34
5adgB-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADI_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.31A 5adiA-2obhA:
undetectable
5adiB-2obhA:
undetectable		 5adiA-2obhA:
16.34
5adiB-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVQ_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.31A 5fvqA-2obhA:
undetectable
5fvqB-2obhA:
undetectable		 5fvqA-2obhA:
17.09
5fvqB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVS_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.31A 5fvsA-2obhA:
undetectable
5fvsB-2obhA:
undetectable		 5fvsA-2obhA:
17.09
5fvsB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVT_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.34A 5fvtA-2obhA:
undetectable
5fvtB-2obhA:
undetectable		 5fvtA-2obhA:
17.09
5fvtB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVT_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.27A 5fvtA-2obhA:
undetectable
5fvtB-2obhA:
undetectable		 5fvtA-2obhA:
17.09
5fvtB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVU_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.27A 5fvuA-2obhA:
undetectable
5fvuB-2obhA:
undetectable		 5fvuA-2obhA:
16.34
5fvuB-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVV_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.30A 5fvvA-2obhA:
undetectable
5fvvB-2obhA:
undetectable		 5fvvA-2obhA:
16.34
5fvvB-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVV_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.28A 5fvvA-2obhA:
undetectable
5fvvB-2obhA:
undetectable		 5fvvA-2obhA:
16.34
5fvvB-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVW_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.30A 5fvwA-2obhA:
undetectable
5fvwB-2obhA:
undetectable		 5fvwA-2obhA:
16.34
5fvwB-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVW_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.29A 5fvwA-2obhA:
undetectable
5fvwB-2obhA:
undetectable		 5fvwA-2obhA:
16.34
5fvwB-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVX_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.30A 5fvxA-2obhA:
undetectable
5fvxB-2obhA:
undetectable		 5fvxA-2obhA:
16.34
5fvxB-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FW0_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.30A 5fw0A-2obhA:
undetectable
5fw0B-2obhA:
undetectable		 5fw0A-2obhA:
17.09
5fw0B-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G0N_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.33A 5g0nA-2obhA:
undetectable
5g0nB-2obhA:
undetectable		 5g0nA-2obhA:
17.09
5g0nB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G0N_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.30A 5g0nA-2obhA:
undetectable
5g0nB-2obhA:
undetectable		 5g0nA-2obhA:
17.09
5g0nB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G0O_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.36A 5g0oA-2obhA:
undetectable
5g0oB-2obhA:
undetectable		 5g0oA-2obhA:
17.09
5g0oB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5GWK_F_EVPF102_1
(DNA TOPOISOMERASE
2-ALPHA)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 5 GLY A  46
ASP A  41
MET A  93
MET A  97
 None
 1.32A 5gwkA-2obhA:
undetectable		 5gwkA-2obhA:
11.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNR_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.39A 5unrA-2obhA:
undetectable
5unrB-2obhA:
undetectable		 5unrA-2obhA:
17.09
5unrB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNS_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.35A 5unsA-2obhA:
undetectable
5unsB-2obhA:
undetectable		 5unsA-2obhA:
17.09
5unsB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNT_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.37A 5untA-2obhA:
undetectable
5untB-2obhA:
undetectable		 5untA-2obhA:
17.09
5untB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNT_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.31A 5untA-2obhA:
undetectable
5untB-2obhA:
undetectable		 5untA-2obhA:
17.09
5untB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNU_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.32A 5unuA-2obhA:
undetectable
5unuB-2obhA:
undetectable		 5unuA-2obhA:
17.09
5unuB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNU_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.32A 5unuA-2obhA:
undetectable
5unuB-2obhA:
undetectable		 5unuA-2obhA:
17.09
5unuB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNW_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.33A 5unwA-2obhA:
undetectable
5unwB-2obhA:
undetectable		 5unwA-2obhA:
17.09
5unwB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNW_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.29A 5unwA-2obhA:
undetectable
5unwB-2obhA:
undetectable		 5unwA-2obhA:
17.09
5unwB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNX_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.35A 5unxA-2obhA:
undetectable
5unxB-2obhA:
undetectable		 5unxA-2obhA:
17.09
5unxB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNY_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.35A 5unyA-2obhA:
undetectable
5unyB-2obhA:
undetectable		 5unyA-2obhA:
17.09
5unyB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNY_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.34A 5unyA-2obhA:
undetectable
5unyB-2obhA:
undetectable		 5unyA-2obhA:
17.09
5unyB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNZ_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.37A 5unzA-2obhA:
undetectable
5unzB-2obhA:
undetectable		 5unzA-2obhA:
17.09
5unzB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO0_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.41A 5uo0A-2obhA:
undetectable
5uo0B-2obhA:
undetectable		 5uo0A-2obhA:
17.09
5uo0B-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO1_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.34A 5uo1A-2obhA:
undetectable
5uo1B-2obhA:
undetectable		 5uo1A-2obhA:
16.34
5uo1B-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO1_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.29A 5uo1A-2obhA:
undetectable
5uo1B-2obhA:
undetectable		 5uo1A-2obhA:
16.34
5uo1B-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO2_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.32A 5uo2A-2obhA:
undetectable
5uo2B-2obhA:
undetectable		 5uo2A-2obhA:
16.34
5uo2B-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO2_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.33A 5uo2A-2obhA:
undetectable
5uo2B-2obhA:
undetectable		 5uo2A-2obhA:
16.34
5uo2B-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO3_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.28A 5uo3A-2obhA:
undetectable
5uo3B-2obhA:
undetectable		 5uo3A-2obhA:
16.34
5uo3B-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO3_B_H4BB803_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.29A 5uo3A-2obhA:
undetectable
5uo3B-2obhA:
undetectable		 5uo3A-2obhA:
16.34
5uo3B-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO4_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.35A 5uo4A-2obhA:
undetectable
5uo4B-2obhA:
undetectable		 5uo4A-2obhA:
16.34
5uo4B-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO4_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.29A 5uo4A-2obhA:
undetectable
5uo4B-2obhA:
undetectable		 5uo4A-2obhA:
16.34
5uo4B-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO5_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.34A 5uo5A-2obhA:
undetectable
5uo5B-2obhA:
undetectable		 5uo5A-2obhA:
16.34
5uo5B-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO5_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.31A 5uo5A-2obhA:
undetectable
5uo5B-2obhA:
undetectable		 5uo5A-2obhA:
16.34
5uo5B-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO6_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.28A 5uo6A-2obhA:
undetectable
5uo6B-2obhA:
undetectable		 5uo6A-2obhA:
16.34
5uo6B-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO7_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 8 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.31A 5uo7A-2obhA:
undetectable
5uo7B-2obhA:
undetectable		 5uo7A-2obhA:
16.34
5uo7B-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO7_B_H4BB803_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.29A 5uo7A-2obhA:
undetectable
5uo7B-2obhA:
undetectable		 5uo7A-2obhA:
16.34
5uo7B-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUI_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.38A 5vuiA-2obhA:
undetectable
5vuiB-2obhA:
undetectable		 5vuiA-2obhA:
17.09
5vuiB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUI_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.30A 5vuiA-2obhA:
undetectable
5vuiB-2obhA:
undetectable		 5vuiA-2obhA:
17.09
5vuiB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUK_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.39A 5vukA-2obhA:
undetectable
5vukB-2obhA:
undetectable		 5vukA-2obhA:
17.09
5vukB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUM_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.39A 5vumA-2obhA:
undetectable
5vumB-2obhA:
undetectable		 5vumA-2obhA:
17.09
5vumB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUS_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.38A 5vusA-2obhA:
undetectable
5vusB-2obhA:
undetectable		 5vusA-2obhA:
17.09
5vusB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUU_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.43A 5vuuA-2obhA:
undetectable
5vuuB-2obhA:
undetectable		 5vuuA-2obhA:
17.09
5vuuB-2obhA:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUV_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.37A 5vuvA-2obhA:
undetectable
5vuvB-2obhA:
undetectable		 5vuvA-2obhA:
16.34
5vuvB-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUV_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.31A 5vuvA-2obhA:
undetectable
5vuvB-2obhA:
undetectable		 5vuvA-2obhA:
16.34
5vuvB-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUW_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.38A 5vuwA-2obhA:
undetectable
5vuwB-2obhA:
undetectable		 5vuwA-2obhA:
16.34
5vuwB-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUY_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.42A 5vuyA-2obhA:
undetectable
5vuyB-2obhA:
undetectable		 5vuyA-2obhA:
16.34
5vuyB-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUZ_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.34A 5vuzA-2obhA:
undetectable
5vuzB-2obhA:
undetectable		 5vuzA-2obhA:
16.34
5vuzB-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUZ_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.36A 5vuzA-2obhA:
undetectable
5vuzB-2obhA:
undetectable		 5vuzA-2obhA:
16.34
5vuzB-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VV3_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.35A 5vv3A-2obhA:
undetectable
5vv3B-2obhA:
undetectable		 5vv3A-2obhA:
16.34
5vv3B-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VV3_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.25A 5vv3A-2obhA:
undetectable
5vv3B-2obhA:
undetectable		 5vv3A-2obhA:
16.34
5vv3B-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VV4_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.27A 5vv4A-2obhA:
undetectable
5vv4B-2obhA:
undetectable		 5vv4A-2obhA:
16.34
5vv4B-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VV5_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.49A 5vv5A-2obhA:
undetectable
5vv5B-2obhA:
undetectable		 5vv5A-2obhA:
16.34
5vv5B-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VV5_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.32A 5vv5A-2obhA:
undetectable
5vv5B-2obhA:
undetectable		 5vv5A-2obhA:
16.34
5vv5B-2obhA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUQ_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.32A 6auqA-2obhA:
undetectable
6auqB-2obhA:
undetectable		 6auqA-2obhA:
20.83
6auqB-2obhA:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUR_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.28A 6aurA-2obhA:
undetectable
6aurB-2obhA:
undetectable		 6aurA-2obhA:
20.83
6aurB-2obhA:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUR_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.29A 6aurA-2obhA:
undetectable
6aurB-2obhA:
undetectable		 6aurA-2obhA:
20.83
6aurB-2obhA:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUS_B_H4BB803_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.35A 6ausA-2obhA:
undetectable
6ausB-2obhA:
undetectable		 6ausA-2obhA:
20.83
6ausB-2obhA:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUT_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.29A 6autA-2obhA:
undetectable
6autB-2obhA:
undetectable		 6autA-2obhA:
20.83
6autB-2obhA:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUT_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.29A 6autA-2obhA:
undetectable
6autB-2obhA:
undetectable		 6autA-2obhA:
20.83
6autB-2obhA:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUU_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.32A 6auuA-2obhA:
undetectable
6auuB-2obhA:
undetectable		 6auuA-2obhA:
20.83
6auuB-2obhA:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUV_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.30A 6auvA-2obhA:
undetectable
6auvB-2obhA:
undetectable		 6auvA-2obhA:
20.83
6auvB-2obhA:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUW_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.37A 6auwA-2obhA:
undetectable
6auwB-2obhA:
undetectable		 6auwA-2obhA:
20.83
6auwB-2obhA:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUW_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.38A 6auwA-2obhA:
undetectable
6auwB-2obhA:
undetectable		 6auwA-2obhA:
20.83
6auwB-2obhA:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUY_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.28A 6auyA-2obhA:
undetectable
6auyB-2obhA:
undetectable		 6auyA-2obhA:
18.18
6auyB-2obhA:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUZ_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.30A 6auzA-2obhA:
undetectable
6auzB-2obhA:
undetectable		 6auzA-2obhA:
18.18
6auzB-2obhA:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUZ_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.28A 6auzA-2obhA:
undetectable
6auzB-2obhA:
undetectable		 6auzA-2obhA:
18.18
6auzB-2obhA:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV0_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.33A 6av0A-2obhA:
undetectable
6av0B-2obhA:
undetectable		 6av0A-2obhA:
18.18
6av0B-2obhA:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV0_B_H4BB803_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.27A 6av0A-2obhA:
undetectable
6av0B-2obhA:
undetectable		 6av0A-2obhA:
18.18
6av0B-2obhA:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV1_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.32A 6av1A-2obhA:
undetectable
6av1B-2obhA:
undetectable		 6av1A-2obhA:
18.18
6av1B-2obhA:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV1_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.31A 6av1A-2obhA:
undetectable
6av1B-2obhA:
undetectable		 6av1A-2obhA:
18.18
6av1B-2obhA:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV2_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.27A 6av2A-2obhA:
undetectable
6av2B-2obhA:
undetectable		 6av2A-2obhA:
18.18
6av2B-2obhA:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV3_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.26A 6av3A-2obhA:
undetectable
6av3B-2obhA:
undetectable		 6av3A-2obhA:
18.18
6av3B-2obhA:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV4_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.36A 6av4A-2obhA:
undetectable
6av4B-2obhA:
undetectable		 6av4A-2obhA:
18.18
6av4B-2obhA:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV4_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.25A 6av4A-2obhA:
undetectable
6av4B-2obhA:
undetectable		 6av4A-2obhA:
18.18
6av4B-2obhA:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV5_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.30A 6av5A-2obhA:
undetectable
6av5B-2obhA:
undetectable		 6av5A-2obhA:
18.18
6av5B-2obhA:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV5_B_H4BB803_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.28A 6av5A-2obhA:
undetectable
6av5B-2obhA:
undetectable		 6av5A-2obhA:
18.18
6av5B-2obhA:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CIC_A_H4BA802_0
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.36A 6cicA-2obhA:
undetectable
6cicB-2obhA:
undetectable		 6cicA-2obhA:
18.18
6cicB-2obhA:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CIC_B_H4BB802_0
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.33A 6cicA-2obhA:
undetectable
6cicB-2obhA:
undetectable		 6cicA-2obhA:
18.18
6cicB-2obhA:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CID_A_H4BA802_0
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 MET A 145
VAL A 157
PHE A 162
GLU A 148
 None
CA  A1001 ( 4.9A)
None
None
 1.34A 6cidA-2obhA:
undetectable
6cidB-2obhA:
undetectable		 6cidA-2obhA:
18.18
6cidB-2obhA:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CID_B_H4BB803_0
(NITRIC OXIDE
SYNTHASE, BRAIN)		 2obh CENTRIN-2
(Homo
sapiens) 		4 / 7 PHE A 162
GLU A 148
MET A 145
VAL A 157
 None
None
None
CA  A1001 ( 4.9A)
 1.31A 6cidA-2obhA:
undetectable
6cidB-2obhA:
undetectable		 6cidA-2obhA:
18.18
6cidB-2obhA:
18.18